Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5933|3|3|279-290

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.3, 2004-01, pp. : 279-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain

By  

Current Pharmaceutical Design, Vol. 21, Iss. 34, 2015-10 ,pp. : 5029-5033

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Chemokine Receptors as Targets in the Therapy of Psoriasis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. : 169-174

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines as Potential Therapeutic Targets in Atherosclerosis

By  

Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. : 13-27

Bentham Science Publishers

Access to resources Recommend Favorite

GABAB Receptors as Potential Therapeutic Targets

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 4, 2003-08 ,pp. : 248-259

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of cannabis in multiple sclerosis

By Baker David   Pryce Gareth  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 561-567

Informa Healthcare

Access to resources Recommend Favorite